NUMG
Nuveen ESG Mid-Cap Growth ETF
The NuShares ESG Mid-Cap Growth ETF tracks an index composed of mid-cap U.S. companies with growth characteristics that also meet certain environmental, social, and governance criteria.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 298.3 M
ASSETS UNDER MGMT
31 bp
EXPENSES
Fund Basics
| Inception date | Dec 13, 2016 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| LUMENTUM HOLDINGS INC | 4.3 % |
| VEEVA SYSTEMS INC-CLASS A | 3.7 % |
| IDEXX LABORATORIES INC | 3.2 % |
| CIENA CORP | 3.1 % |
| COMFORT SYSTEMS USA INC | 2.9 % |
| ULTA BEAUTY INC | 2.9 % |
| KEYSIGHT TECHNOLOGIES INC | 2.8 % |
| ZSCALER, INC. | 2.8 % |
| ATLASSIAN CORP. CLASS A | 2.8 % |
| RESMED INC | 2.8 % |
Constituent Breakdown
| Number of holdings | 45 |
| Herfindahl-Hirschman Index | 245 |
| Wgt avg mkt cap (mns) | $32,503 |
| Large cap (>$10bn) | 95.9% |
| Mid cap ($2-10bn) | 0.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 95.9% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 89.6 % |
 |
AUSTRALIA | 2.8 % |
 |
BRITAIN | 2.0 % |
 |
CAYMAN ISLANDS | 1.5 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -5.2% | -7.1% | 0.5% | 7.3% | -3.6% | -- | -- | 6.2% |
| Dividend Yield | 0.0% | 0.0% | 0.0% | 0.1% | 2.4% | -- | -- | 2.5% |
| Total Returns | -5.2% | -7.1% | 0.5% | 7.4% | -1.2% | -- | -- | 8.7% | Ann. Volatility | 20.2% | 19.2% | 21.4% | 20.2% | 23.1% | -- | -- | 21.8% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.13 | 58% |
| MSCI EAFE | 0.68 | 31% |
| MSCI Emg Mkts | 0.42 | 30% |
Liquidity Measures
| Avg. volume (000) | 46 |
| ADV traded (mns) | $2 |
| Turnover | 0.7% |
| Avg. Bid/Ask (% of price) | 0.16% |
Technical Indicators
| 30d moving avg. (EMA) | $45.98 |
| Relative strength (RSI) | 45 |
| MACD/Signal | -0.34/-0.21 |
| Bollinger Bands (Upper/Lower) | $47.86/$44.28 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. NUMG |
Expenses vs. NUMG |
ALTAR Score™ vs. NUMG |
|---|---|---|---|---|
| VOT | Vanguard Mid-Cap Growth ETF | 19.8% | -26 bp | +1.7% |
| IWP | iShares Russell Mid-Cap Growth ETF | 18.5% | -8 bp | +1.7% |
| TMFX | Motley Fool Next Index ETF | 15.9% | +19 bp | +1.1% |
| ABOT | Abacus FCF Innovation Leaders ETF | 14.4% | +28 bp | +2.6% |
| TMFM | Motley Fool Mid-Cap Growth ETF | 13.9% | +54 bp | +1.0% |
| NULG | Nuveen ESG Large-Cap Growth ETF | 13.8% | -5 bp | +1.9% |
| IMCG | iShares Morningstar Mid-Cap Growth ETF | 13.7% | -25 bp | +1.9% |
| CGMM | Capital Group U.S. Small and Mid Cap Equity ETF | 13.3% | +20 bp | +2.5% |
| QQQJ | Invesco NASDAQ Next Gen 100 ETF | 12.5% | -16 bp | +2.1% |
| FTC | First Trust Large Cap Growth AlphaDEX Fund | 12.4% | +27 bp | +1.0% |
Risk and Returns: NUMG vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
2.3%
ALTAR SCORE™
5th
PERCENTILE
AVOID
ETFRC RATING
There are 1,388 funds in the US Equity category with an average
ALTAR Score™ of 5.7% and a standard deviation
of 2.1%. NUMG's ALTAR Score™ is approximately -1.6 standard
deviations above the category average. This places NUMG in the 5th percentile
among funds in the category.
Sell-Side Consensus
$56.47
PRICE TARGET
+31.8%
UPSIDE